Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term **"Antiparasitic activity"** is not the name of a molecule, receptor, enzyme, or other therapeutic target; rather, it describes a **pharmacological property** or effect in which a substance inhibits the growth of or kills parasites. **Antiparasitic agents** are drugs designed to treat infections caused by parasites, including helminths (worms), protozoa, and ectoparasites (such as lice, fleas, and mites)[1][2][3][6]. Medication classes within antiparasitics include anthelmintics (against worms), antiprotozoals (against protozoans), and ectoparasiticides (against ectoparasites). Each specific drug acts on particular molecular targets within the parasite, but "antiparasitic activity" itself is not a single defined therapeutic target and cannot be classified as such. Thus, there is something wrong with considering "Antiparasitic activity" as a target in the strict biomedical sense. It is a broad pharmacodynamic property applicable to many chemically diverse agents with different modes of action[1][2][3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antiparasitic activity.